Company Profile

ATGC Inc
Profile last edited on: 1/23/2018      CAGE: 7FJ59      UEI: F3KRQG95DCF6

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1992
First Award
2017
Latest Award
2023
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

35 Waltz Drive
Wheeling, IL 60090
   (800) 557-2248
   N/A
   www.acgtinc.com
Location: Multiple
Congr. District: 10
County: Cook

Public Profile

Based in Wheeling IL, with Lab facailites in MD, ACGT, Inc. a contract research service company, providing a range of DNA sequencing and molecular biology services to pharmaceutical, biotechnology, academic, and government sectors. The firm's DNA sequencing services include quick single pass DNA sequencing, direct colony sequencing, full sequence analysis, high throughput DNA sequencing, shotgun DNA sequencing, specialty DNA sequencing, microbial ID DNA sequencing, and FDA DNA sequencing. The company also offers next generation sequencing services comprising whole genome sequencing, transcriptome analysis, DNA methylatlon analysis, chromatin immunoprecipitation sequence analysis, and metagenomic analysis; and genotyping services consisting of SNP genotyping, STR genotyping, genotyping by PCR, and genotyping by DNA sequencing. In addition, it provides various genomic services that include quantitative PCR analysis, cDNA cloning, cDNA library construction, gene mutagenesis, custom gene synthesis, and DNA RNA extraction; and contract research services, including project support, sample processing, pharmacogenomic support, and transgenic support.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
100-149
Revenue Range
10M-15M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $259,520
Project Title: Rapid egg bioreactor construction for Fabry disease therapeutics
2022 2 NIH $2,333,514
Project Title: Novel methods to improve nuclease mediated homologous recombination
2019 2 NIH $1,707,545
Project Title: A nanoparticle delivery system for CRISPR/Cas9 based therapeutics
2017 1 NIH $225,750
Project Title: Ground state rabbit pluripotent stem cells
0 1 NIH $274,955
Project Title: Structure-based computational engineering of saCas9 PAM requirement

Key People / Management

  Xiaoqiang Huang

  Peter X Ma

  Jie Xu

  Qilong Ying

  Jifeng Zhang

Company News

There are no news available.